These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8016717)

  • 21. Changes in Saliva Rheological Properties and Mucin Glycosylation in Dry Mouth.
    Chaudhury NM; Shirlaw P; Pramanik R; Carpenter GH; Proctor GB
    J Dent Res; 2015 Dec; 94(12):1660-7. PubMed ID: 26446936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How much saliva is enough for avoidance of xerostomia?
    Dawes C
    Caries Res; 2004; 38(3):236-40. PubMed ID: 15153694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of a saliva wetness tester and a moisture-checking device in patients with maxillary obturator prostheses.
    Murakami M; Nishi Y; Kamashita Y; Nagaoka E
    Gerodontology; 2014 Jun; 31(2):83-8. PubMed ID: 23421873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dental implications of xerostomia. A review of the literature.
    Wallace MC; Petrusneck F
    J Ala Dent Assoc; 1985; 69(1):44-7. PubMed ID: 3855911
    [No Abstract]   [Full Text] [Related]  

  • 25. Saliva secretion and abnormal moistening of oral mucosa after bone marrow transplantation.
    Bogusławska-Kapała A; Cackowska-Lass A; Balon J; Hellmann A; Kochańska B
    Bull Group Int Rech Sci Stomatol Odontol; 2006 Mar; 47(1):1-5. PubMed ID: 17672198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of the Schirmer tear test in evaluating mouth dryness.
    Davis CC; Marks JE
    Dent Hyg (Chic); 1986 Mar; 60(3):116-9, 129. PubMed ID: 3457730
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnosis and management of post-radiation dryness of mucosas].
    de La Torre Tomás A; Verd Herrero JJ
    Rev Clin Esp; 2001 Nov; 201(11):642-4. PubMed ID: 11786131
    [No Abstract]   [Full Text] [Related]  

  • 28. The prevalence of xerostomia in patients with removable prostheses.
    Nikolopoulou F; Tasopoulos T; Jagger R
    Int J Prosthodont; 2013; 26(6):525-6. PubMed ID: 24179964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigating the relationship between hyposalivation and mucosal wetness.
    Osailan S; Pramanik R; Shirodaria S; Challacombe SJ; Proctor GB
    Oral Dis; 2011 Jan; 17(1):109-14. PubMed ID: 21029258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dry mouth].
    Reiss M; Reiss G
    Med Monatsschr Pharm; 2006 Apr; 29(4):129-36; quiz 137-8. PubMed ID: 16628962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
    Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of specified stressors on healthy oral mucosa.
    DeWalt EM; Haines AK
    Nurs Res; 1969; 18(1):22-7. PubMed ID: 5189611
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnosis and management of the dry mouth: Part 1.
    Pankhurst CL; Smith EC; Rogers JO; Dunne SM; Jackson SH; Proctor G
    Dent Update; 1996 Mar; 23(2):56-62. PubMed ID: 8948194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xerostomia and you.
    Hay KD; Gear KJ
    N Z Dent J; 2002 Jun; 98(432):46-51. PubMed ID: 12125329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
    Nederfors T
    Swed Dent J Suppl; 1996; 116():1-70. PubMed ID: 8813731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug induced xerostomia. The effects and treatment.
    Grad H; Grushka M; Yanover L
    J Can Dent Assoc; 1985 Apr; 51(4):296-300. PubMed ID: 3891040
    [No Abstract]   [Full Text] [Related]  

  • 37. Removable prosthodontic therapy and xerostomia. Treatment considerations.
    Massad JJ; Cagna DR
    Dent Today; 2002 Jun; 21(6):80-2, 84, 86-7. PubMed ID: 12073484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognition and treatment of salivary induced conditions.
    Sreebny LM
    Int Dent J; 1989 Sep; 39(3):197-204. PubMed ID: 2676866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial.
    Alves MB; Motta AC; Messina WC; Migliari DA
    Quintessence Int; 2004 May; 35(5):392-6. PubMed ID: 15130080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a Visual Analogue Scale questionnaire for subjective assessment of salivary dysfunction.
    Pai S; Ghezzi EM; Ship JA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):311-6. PubMed ID: 11250628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.